Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Precision Oncology Market: By Type, By End User and Region Forecast 2019-2030
Precision Oncology Market size was valued at US$ 49.5 billion in 2023 and is poised to grow at a CAGR of 10.1% from 2024 to 2030. Precision oncology is a cutting-edge kind of cancer therapy that makes sure your care is tailored to your particular type of cancer. It is the science of harnessing the unique genetics of each patient the genes that are mutated and cause their disease to spread to develop a personalized treatment plan based on those genetic mutations.
The global market provides a detailed overview of the market, which has been segmented by type and end-user. By type, the market has been segmented into consumable Instruments and Services. The Consumable segment is likely to be the largest and fastest-growing in terms of type. Precision oncology is segmented into Pharmaceuticals Companies, Biotechnology Companies, Diagnostic Companies, and CROs based on the end-user. According to precision business insights, the Diagnostic Companies segment is predicted to register the fastest growth rate during the forecast period.
Study Period
2024-2030Base Year
2023CAGR
10.1%Largest Market
Asia PacificFastest Growing Market
North America
Precision medicine combines molecular biology and system biology and is a new cancer treatment and prevention approach. Oncology precision medicine has emerged as potentially transformational, promising more excellent treatment outcomes for all cancer patients.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2023 |
US$ 49.5 billion |
Market CAGR |
10.1% |
By Type |
|
By End User |
|
By Region |
|
Download Free Sample Report
The global precision oncology market size was valued at US$ 49.5 billion in 2023 and is projected to grow at a CAGR of 10.1% from 2024-2030.
The major global precision oncology market players are Eagle Genomics, ASEBIO, Menarini Silicon Biosystems, NanoString Technologies, Inc., NeoGenomics, QIAGEN, and Tepnel Pharma Services.
North America is the fastest-growing region for precision oncology market
1. Executive Summary |
2. Global Precision Oncology Market Introduction |
2.1. Global Precision Oncology Market Taxonomy |
2.2. Global Precision Oncology Market Definitions |
2.2.1. By End-user |
2.2.2. By Type |
3. Global Precision Oncology Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Precision Oncology Market Dynamic Factors - Impact Analysis |
3.6. Global Precision Oncology Market Competition Landscape |
4. Global Precision Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 |
4.1. Market Analysis,2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Precision Oncology Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1. Pharmaceuticals Companies |
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Biotechnology Companies |
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Diagnostic Companies |
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. CROs |
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3. Market Opportunity Analysis |
6. Global Precision Oncology Market Forecast, By Type, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1. Consumable |
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Instruments |
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Services |
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7. Global Precision Oncology Market Forecast, By Region, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1. North America |
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa |
7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Region, 2024 - 2030 |
8. North America Precision OncologyMarketAnalysis,2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
8.1. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Pharmaceuticals Companies |
8.1.2. Biotechnology Companies |
8.1.3. Diagnostic Companies |
8.1.4. CROs |
8.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
8.2.1. Consumable |
8.2.2. Instruments |
8.2.3. Services |
8.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
8.3.1. USA |
8.3.2. Canada |
8.4. North America Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country, 2024 - 2030 |
8.5. North America Precision Oncology Market Dynamics Trends |
9. Europe Precision Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
9.1. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Pharmaceuticals Companies |
9.1.2. Biotechnology Companies |
9.1.3. Diagnostic Companies |
9.1.4. CROs |
9.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
9.2.1. Consumable |
9.2.2. Instruments |
9.2.3. Services |
9.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Germany |
9.3.2. UK |
9.3.3. France |
9.3.4. Spain |
9.3.5. Italy |
9.3.6. Russia |
9.3.7. Poland |
9.3.8. Rest of Europe |
9.4. Europe Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2024 - 2030 |
9.5. Europe Precision Oncology Market Dynamics Trends |
10. Asia-Pacific Precision Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
10.1. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Pharmaceuticals Companies |
10.1.2. Biotechnology Companies |
10.1.3. Diagnostic Companies |
10.1.4. CROs |
10.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
10.2.1. Consumable |
10.2.2. Instruments |
10.2.3. Services |
10.3. Country Analysis2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Japan |
10.3.2. China |
10.3.3. India |
10.3.4. ASEAN |
10.3.5. Australia & New Zealand |
10.3.6. Rest of Asia-Pacific |
10.4. Asia-Pacific Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2024 - 2030 |
10.5. Asia-Pacific Precision Oncology Market Dynamics Trends |
11. Latin America Precision Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
11.1. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Pharmaceuticals Companies |
11.1.2. Biotechnology Companies |
11.1.3. Diagnostic Companies |
11.1.4. CROs |
11.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
11.2.1. Consumable |
11.2.2. Instruments |
11.2.3. Services |
11.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Brazil |
11.3.2. Mexico |
11.3.3. Argentina |
11.3.4. Rest of Latin America |
11.4. Latin America Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2024 - 2030 |
11.5. Latin America Precision Oncology Market Dynamics Trends |
12. Middle East and Africa Precision Oncology Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030 (Revenue, USD Mn) |
12.1. End-user Analysis 2019 - 2023 and Forecast 2024 - 2030by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Pharmaceuticals Companies |
12.1.2. Biotechnology Companies |
12.1.3. Diagnostic Companies |
12.1.4. CROs |
12.2. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%) |
12.2.1. Consumable |
12.2.2. Instruments |
12.2.3. Services |
12.3. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Gulf Cooperation Council (GCC) Countries |
12.3.2. Israel |
12.3.3. South Africa |
12.3.4. Rest of MEA |
12.4. MEA Precision Oncology Market - Opportunity Analysis Index, By End-user, By Type and Country,2024 - 2030 |
12.5. MEA Precision Oncology Market Dynamics Trends |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. Eagle Genomics |
13.2.2. ASEBIO |
13.2.3. Menarini Silicon Biosystems |
13.2.4. NanoString Technologies, Inc. |
13.2.5. NeoGenomics |
13.2.6. QIAGEN |
13.2.7. Tepnel Pharma Services |
14. Research Methodology |
15. Key Assumptions and Acronyms |
Key Market Players